MedTrace Logo

Pulmonary Inflammation in COVID-19 ARDS

NCT04935450 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2021-06-23

No results posted yet for this study

Summary

Patients older than 18 years of age, with COVID-19 related ARDS (C-ARDS) hospitalized in the ICU and invasively mechanically ventilated will be included in the study.

This is an observational cohort study. After informed consent by the next of kin, and within the first 72 hours of invasive mechanical ventilation a blood and a Broncho Alveolar Lavage Fluid (BALF) sample will be collected. If the patients remain invasively mechanically ventilated a second and third blood and BALF sample will be collected every 7-10 days.

Conditions

  • ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
  • COVID-19 Acute Respiratory Distress Syndrome

Interventions

DIAGNOSTIC_TEST

Bronchoalveolar lavage

Low volume Broncho alveolar lavage. During optic flexible bronchoscopy through the tracheal tube or the tracheostomy cannula a maximum of 4 aliquots of 20 ml normal saline will be instilled in a wedged position in the right medium lobe of the patients and then aspirated untill reaching a total of 25ml of fluid (BALF) for analysis

Sponsors & Collaborators

  • Hospital Universitario Ramon y Cajal

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-12
Primary Completion
2021-08-15
Completion
2021-08-16

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04935450 on ClinicalTrials.gov